Resources: Healthspan Economics, Policy, and Research
The scientific and public policy communities supportive of and opposed to the treatment of the systemic causes of aging-related disease represent a diverse landscape of perspective. In collaboration with our Fellows, we’ve compiled a consortium of resources pertaining to the public policy, scientific research, and economic impacts of healthspan science and technologies, to assist our supporters in getting completely up-to-date on the newest innovations.
The Economic Impact:
By 2030, the number of U.S. adults aged 65 years or older will more than double to about 71 million, and Medicare spending will increase by 25% ($9 billion). Currently, one-third of all Medicare spending ($15,000 per person) is tied to aging-related disease. At the same time, the economic value of treating the underlying causes of aging-related disease in the U.S. alone – instead of just one disease at a time – is projected at $7.1 trillion for the next 50 years. Learn more here.
The Public Policy Implications:
How do we regulate a new class of pharmaceuticals, therapies, and treatments that seek to address the issues that are happening in our bodies right now that lead to cancer, Alzheimer’s, and a host of other debilitating aging-related diseases? What are the costs and benefits to the world as a whole – and how do we ethically ensure access for citizens of all incomes and geographic locations? If these questions pique your interest, look no further.
What exactly are the systemic causes that lead to aging-related disease? If you’re looking for these answers, you’ll find a collection of brilliant and proven theories by some of the world’s leading researchers on the topic right here.
The International Aging Research Portfolio (IARP) is an independent joint initiative of government, academic, corporate, patient advocacy and charitable funding organizations. AgingPortfolio.Org system is a flexible system to enable funding organizations to collaborate, track, analyze, structure, make decisions and set directions for future research efforts in aging and also address the needs of research investigators, health care policy makers, government officials, interest groups and general public. If you are looking for potential grants and funding, this is the place to start.